Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 220

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 220
---
 December 31, 2022— $— 208,150,021 $— — $— $1,998,314 $(3,488)$(1,868,567)$126,259 

The accompanying notes are an integral part of these consolidated financial statements.

F-9

Precigen, Inc. and Subsidiaries

Consolidated Statements of Mezzanine Equity and Shareholders' Equity

Years Ended December 31, 2024, 2023, and 2022 

(Amounts in thousands, except share data)Mezzanine Stock Common StockTreasury StockAdditionalPaid-inCapitalAccumulatedOtherComprehensive(Loss) IncomeAccumulatedDeficitTotalShareholders'EquitySharesAmountSharesAmountSharesAmountBalances at December 31, 2022— $— 208,150,021 $— — $— $1,998,314 $(3,488)$(1,868,567)$126,259 Stock-based compensation expense— — — — — — 9,888 — — 9,888 Shares issued upon vesting of restricted stock units and forexercises of stock options— — 751,233 — — — — — — — Shares issued for accrued compensation— — 3,068,825 — — — 3,361 — — 3,361 Shares issued as payment for services— — 465,808 — — — 545 — — 545 Shares issued in public offering, net of issuance costs— — 43,962,640 — — — 72,808 — — 72,808 Shares returned pursuant to share lending agreement— — (7,479,431)— 7,479,431 — — — — — Net loss— — — — — — — — (95,904)(95,904)Other comprehensive income— — — — — — — 1,541 — 1,541 Balances at December 31, 2023— $— 248,919,096 $— 7,479,431 $— $2,084,916 $(1,947